The Crystal Ball and The American Healthcare System in 2021

This outlook reviews some of the interesting aspects of the US healthcare industry and shares SGA’s perspective based on internal research, survey and KOL feedback in Q4, 2020. 

Download this whitepaper to know more about the lessons learnt from the year 2020, the uncertainties expected in 2021, and the silver linings.

Key Highlights:

  • In 2020, medical devices and surgical accessories suppliers registered losses as elective and non-elective surgeries were postponed extensively all over the US
  • In 2021, pharma companies are expected to spend more on HEOR and related processes
  • In 2021, predictive analytics takes the centre-stage – Mix of new and old companies ready with innovative AI/ML-backed healthcare products with FDA approval

    Get all of our articles and insights as soon as they're published.

    By sharing the information you have entered, you give your express consent to SG Analytics to use the provided information to contact you with relevant information related to its offerings and services as and when required. SG Analytics secures all your personal information from unauthorized access, use or disclosure. For more information, please visit our privacy policy.